ArticlebioRxiv : the preprint server for biology2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.
John T Phoenix et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.